DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Barker AF, O'Donnell AE, Flume P. et al.
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.
Lancet Respir Med 2014;
2 (09) 738-749
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.